154 related articles for article (PubMed ID: 9349670)
1. Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson's disease.
Mally J; Szalai G; Stone TW
J Neurol Sci; 1997 Oct; 151(2):159-62. PubMed ID: 9349670
[TBL] [Abstract][Full Text] [Related]
2. Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease.
Jiménez-Jiménez FJ; Molina JA; Vargas C; Gómez P; Navarro JA; Benito-León J; Ortí-Pareja M; Gasalla T; Cisneros E; Arenas J
J Neurol Sci; 1996 Sep; 141(1-2):39-44. PubMed ID: 8880690
[TBL] [Abstract][Full Text] [Related]
3. Alteration of amino acids in cerebrospinal fluid from patients with Parkinson's disease and spinocerebellar degeneration.
Araki K; Takino T; Ida S; Kuriyama K
Acta Neurol Scand; 1986 Feb; 73(2):105-10. PubMed ID: 3705920
[TBL] [Abstract][Full Text] [Related]
4. Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease.
Engelborghs S; Marescau B; De Deyn PP
Neurochem Res; 2003 Aug; 28(8):1145-50. PubMed ID: 12834252
[TBL] [Abstract][Full Text] [Related]
5. DOPA and amino acid levels in plasma and cerebrospinal fluid of patients with Parkinson's disease before and during treatment with L-DOPA.
Hare TA; Beasley BL; Chambers RA; Boehme DH; Vogel WH
Clin Chim Acta; 1973 May; 45(3):273-80. PubMed ID: 4708057
[No Abstract] [Full Text] [Related]
6. Ventricular cerebrospinal fluid concentrations of putative amino acid transmitters in Parkinson's disease and other disorders.
Perschak H; Amsler U; Vischer A; Siegfried J; Cuénod M
Hum Neurobiol; 1987; 6(3):191-4. PubMed ID: 2896652
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid amino compounds in Parkinson's disease. Alterations due to carbidopa/levodopa.
Manyam BV; Ferraro TN; Hare TA
Arch Neurol; 1988 Jan; 45(1):48-50. PubMed ID: 3337677
[TBL] [Abstract][Full Text] [Related]
8. [Free amino acids in blood and cerebrospinal fluid in Parkinson's disease].
TORRE M; SCARZELLA R; ZANALDA A
Minerva Med; 1953 Jul; 44(59-60):256. PubMed ID: 13110848
[No Abstract] [Full Text] [Related]
9. L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients.
Kuiper MA; Teerlink T; Visser JJ; Bergmans PL; Scheltens P; Wolters EC
J Neural Transm (Vienna); 2000; 107(2):183-9. PubMed ID: 10847559
[TBL] [Abstract][Full Text] [Related]
10. A significant reduction of putative transmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease and spinocerebellar degeneration.
Tohgi H; Abe T; Hashiguchi K; Takahashi S; Nozaki Y; Kikuchi T
Neurosci Lett; 1991 May; 126(2):155-8. PubMed ID: 1681472
[TBL] [Abstract][Full Text] [Related]
11. Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson's disease.
Molina JA; Jiménez-Jiménez FJ; Gomez P; Vargas C; Navarro JA; Ortí-Pareja M; Gasalla T; Benito-León J; Bermejo F; Arenas J
J Neurol Sci; 1997 Sep; 150(2):123-7. PubMed ID: 9268238
[TBL] [Abstract][Full Text] [Related]
12. [The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. II. Alterations of cerebrospinal fluid in patients with Parkinson's disease and chorea following the administration of alpha-methyldopa].
Gründig E; Gerstenbrand F; Bruck J; Gnad H; Prosenz P; Simanyi M
Dtsch Z Nervenheilkd; 1969; 196(3):256-65. PubMed ID: 5820717
[No Abstract] [Full Text] [Related]
13. Free amino acids in the cerebrospinal fluid in old age and in Parkinson's disease.
Gjessing LR; Gjesdahl P; Dietrichson P; Presthus J
Eur Neurol; 1974; 12(1):33-7. PubMed ID: 4413508
[No Abstract] [Full Text] [Related]
14. Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease.
Abe T; Isobe C; Murata T; Sato C; Tohgi H
Neurosci Lett; 2003 Jan; 336(2):105-8. PubMed ID: 12499051
[TBL] [Abstract][Full Text] [Related]
15. Amino acid abnormalities in cerebrospinal fluid and blood serum of patients with Parkinson's disease, other heredodegenerative disorders and head injuries.
Lakke JP; Teelken AW; vd Voet H; Wolthers BG
Adv Neurol; 1987; 45():243-7. PubMed ID: 3825697
[No Abstract] [Full Text] [Related]
16. Amino acid abnormalities in cerebrospinal fluid of patients with parkinsonism and extrapyramidal disorders.
Lakke JP; Teelken AW
Neurology; 1976 May; 26(5):489-93. PubMed ID: 944400
[TBL] [Abstract][Full Text] [Related]
17. Species fractionation in a case-control study concerning Parkinson's disease: Cu-amino acids discriminate CSF of PD from controls.
Willkommen D; Lucio M; Schmitt-Kopplin P; Gazzaz M; Schroeter M; Sigaroudi A; Michalke B
J Trace Elem Med Biol; 2018 Sep; 49():164-170. PubMed ID: 29472131
[TBL] [Abstract][Full Text] [Related]
18. Expression of hepatocyte growth factor in the serum and cerebrospinal fluid of patients with Parkinson's disease.
Salehi Z; Rajaei F
J Clin Neurosci; 2010 Dec; 17(12):1553-6. PubMed ID: 20829049
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma concentrations of aspartate, glutamate and glycine in Parkinson's disease.
Iwasaki Y; Ikeda K; Shiojima T; Kinoshita M
Neurosci Lett; 1992 Oct; 145(2):175-7. PubMed ID: 1361223
[TBL] [Abstract][Full Text] [Related]
20. Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson's disease.
Trupp M; Jonsson P; Ohrfelt A; Zetterberg H; Obudulu O; Malm L; Wuolikainen A; Linder J; Moritz T; Blennow K; Antti H; Forsgren L
J Parkinsons Dis; 2014; 4(3):549-60. PubMed ID: 24927756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
